Skip to main content

$0.075 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
5 June 2026 at 7:27am
Register to track PAA and receive email alerts.

Update on Phase IIb Clinical Trial of Monepantel in Pet Dogs

StockBot

416,823 posts

PAA released this announcement to the ASX on 30 March 2021, 9:06. The announcement is marked as price sensitive, and is 2 page(s) in length and 392.54kb in size.

You can view all announcements from PAA and see how they appear on a price chart on the announcements page.

At the date of this announcement, PAA was 0.006% short sold according to ASIC data. It was ranked the 608th most shorted stock on the ASX. It is now ranked as the 492nd most shorted stock on the ASX with 0.022% of total shares short sold as of the latest reported data (11 October 2024).

Other Recent Announcements from PAA
Results of General Meeting 30 June 2023, 12:38
Trading Halt 30 June 2023, 9:48
General Meeting - Chairman Script 30 June 2023, 9:42
Update on Phase IIb Clinical Trial of Monepantel in Pet Dogs 30 March 2021, 9:06
Epichem business support program for advanced technologies 29 March 2021, 8:25
Licensing Agreement to Develop Waste to Fuels Technology 23 March 2021, 8:49
Appendix 4D & Half Year Report 26 February 2021, 14:37
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track PAA and receive email alerts.